Hospitalizations are increasing among minority patients with Crohn's disease and ulcerative colitis
β Scribed by Justin L. Sewell; Hal F. Yee Jr; John M. Inadomi
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 182 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1078-0998
No coin nor oath required. For personal study only.
β¦ Synopsis
Background:
Rates of inflammatory bowel disease (ibd) appear to be increasing among nonwhite populations outside the united states, but national data describing the incidence and prevalence of ibd are not available for minority patients. the aim of this study was to examine time trends of hospital discharge among minority patients with ibd.
Methods:
Nationally representative data describing hospital discharges were obtained from the national hospital discharge survey for the years 1994 to 2006. race-specific annual proportions of hospitalizations including a discharge diagnosis of ulcerative colitis and crohn's disease were calculated. trends in proportions were assessed for statistical significance using the extended mantel-haenszel chi-square test for trend.
Results:
The proportion of hospitalizations including a discharge diagnosis of ibd increased significantly from 1994 to 2006 among the total population and among asian, black, and white patients separately. increases were statistically significant when analysis was performed for crohn's disease and ulcerative colitis combined and separately. marked increases were seen among asians.
Conclusions:
The proportion of hospitalizations including a discharge diagnosis of ibd increased significantly among minority and nonminority patients from 1994 through 2006. the causes underlying these changes are not certain and should be further investigated.
π SIMILAR VOLUMES
Levels of the cytokines interleukin-1 -a, -I$, and-2 (IL-1-a, IL-1-0, IL-2), tumornecrosis factor-cc (TNF-a), and interferon--/ (IFN-y) were measured in the mitogen-stimulated whole blood cell cultures from 96 patients with Crohn's disease (48 untreated, 12 treated with sulfasalazine, 36 treated wit
To minimize the possibility of developing lethal colorectal cancer (CRC) in ulcerative colitis (UC) and Crohn's colitis, patients are usually enrolled in a program of dysplasia surveillance. The success of a surveillance program depends on the identification of patients with dysplasia and timely ref